Ionis Pharmaceuticals(IONS) - 2025 Q1 - Earnings Call Presentation

Q1:2025 Business Update and Financial Results April 30, 2025 Nasdaq: IONS 1 On Today's Earnings Call Richard Geary, Ph.D. Chief Development Officer Eugene Schneider, M.D. Chief Clinical Development Officer 2 Eric Swayze, Ph.D. Executive Vice President, Research Brett Monia, Ph.D. Chief Executive Officer Kyle Jenne Chief Global Product Strategy Officer Beth Hougen Chief Financial Officer Jonathan Birchall Chief Commercial Officer Forward-Looking Statements This presentation includes forward-looking statement ...